Winnipeg, Canada

Xiangguo Qiu

USPTO Granted Patents = 5 

 

Average Co-Inventor Count = 3.7

ph-index = 3

Forward Citations = 48(Granted Patents)


Location History:

  • Manitoba, CA (2013)
  • Winnipeg, CA (2015 - 2021)

Company Filing History:


Years Active: 2013-2021

Loading Chart...
Loading Chart...
5 patents (USPTO):Explore Patents

Title: The Innovations of Xiangguo Qiu

Introduction

Xiangguo Qiu is a prominent inventor based in Winnipeg, Canada. He has made significant contributions to the field of virology, particularly in the development of methods to combat filovirus and flavivirus diseases. With a total of five patents to his name, Qiu's work has garnered attention for its potential impact on public health.

Latest Patents

Among his latest patents is a method for preventing or treating filovirus and flavivirus diseases. This innovative approach involves administering an effective amount of quercetin-3 β-O-D-glucoside (Q3G) or an analogue thereof to a mammal host prior to exposure to a filovirus, such as Ebola or Zika virus. Another notable patent includes the development of monoclonal antibodies for Ebola and Marburg viruses, which are crucial for therapeutic interventions against these deadly pathogens.

Career Highlights

Qiu has worked with Her Majesty the Queen in the Right of Canada as represented by the Minister of Health. His research has been instrumental in advancing our understanding of viral infections and developing effective treatments.

Collaborations

Throughout his career, Qiu has collaborated with esteemed colleagues, including Steven J. Jones and Heinz Feldmann. These partnerships have enhanced the scope and impact of his research.

Conclusion

Xiangguo Qiu's innovative work in virology and his contributions to the development of treatments for serious viral diseases highlight his importance as an inventor. His patents reflect a commitment to improving public health and advancing scientific knowledge.

This text is generated by artificial intelligence and may not be accurate.
Please report any incorrect information to support@idiyas.com
Loading…